Economic Burden of Fungal Diseases in the United States
- PMID: 35350173
- PMCID: PMC8946773
- DOI: 10.1093/ofid/ofac097
Economic Burden of Fungal Diseases in the United States
Abstract
We conservatively estimated the US economic burden of fungal diseases as $11.5 billion in 2019: direct medical costs ($7.5 billion), productivity loss due to absenteeism ($870 million), and premature deaths ($3.2 billion). An alternative "value of statistical life" approach yielded >$48 billion. These are likely underestimates given underdiagnosis and underreporting.
Keywords: United States; costs and cost analysis; deaths; hospitalization.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
References
-
- Centers for Medicare & Medicaid Services. Table 23 National Health Expenditures; Nominal, Real, Price Indexes. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Tren.... Accessed 1 April 2021.
-
- Bureau of Labor Statistics. May 2019 National Occupational Employment and Wage Estimates United States. Washington: US Department of Labor; Available at: https://www.bls.gov/oes/current/oes_nat.htm#00-0000. Accessed 8 May 2018.